Sunesh Kumar

Sunesh Kumar

Auto-generated profile, based on publicly available information

Sunesh Kumar

Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2008 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
SKSunesh Kumar
Sunesh Kumar
JSJ. B. Sharma
J. B. Sharma
DVDipika Verma
Dipika Verma
PGPratima Gupta
Pratima Gupta
KRK. K. Roy
K. K. Roy
NMNeena Malhotra
Neena Malhotra

1 January 2016 in Biomarkers in Cancer
Verified
Journal Article
Open access
USUrmila Sehrawat
Urmila Sehrawat
RPRuchika Pokhriyal
Ruchika Pokhriyal
AGAshish Kumar Gupta
Ashish Kumar Gupta
RHRoopa Hariprasad
Roopa Hariprasad
MKMohd Imran Khan
Mohd Imran Khan
GHGururao Hariprasad
Gururao Hariprasad
Conventional treatment for advanced ovarian cancer is an initial debulking surgery followed by chemotherapy combination of carboplatin and paclitaxel. Despite initial high response, three-fourths of these women experience disease recurrence with a dismal prognosis. Patients with advanced-stage ovarian cancer who underwent cytoreductive surgery were enrolled and tissue samples were collected. Post surgery, these patients were started on chemotherapy and followed up till the end of the cycle. Fluorescence-based differential in-gel expression coupled with mass spectrometric analysis was used for discovery phase of experiments, and real-time polymerase chain reaction, Western blotting, and pathway analysis were performed for expression and functional validation of differentially expressed proteins. While aldehyde reductase, hnRNP, cyclophilin A, heat shock protein-27, and actin are upregulated in responders, prohibitin, enoyl-coA hydratase, peroxiredoxin, and fibrin-β are upregulated in the nonresponders. The expressions of some of these proteins correlated with increased apoptotic activity in responders and decreased apoptotic activity in nonresponders. Therefore, the proteins qualify as potential biomarkers to predict chemotherapy response.

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BKBinny Khandakar
Binny Khandakar
SMSandeep R. Mathur
Sandeep R. Mathur
LKLalit Kumar
Lalit Kumar
SKSunesh Kumar
Sunesh Kumar
SGSiddhartha Datta Gupta
Siddhartha Datta Gupta
MKM. Kalaivani
M. Kalaivani
Serous ovarian cancer (SOC) is a significant cause of morbidity and mortality in females with poor prognosis because of advanced stage at presentation. Recently, neoadjuvant chemotherapy (NACT) is being used for management of advanced SOC, but role of tissue biomarkers in prognostication following NACT is not well established. The study was conducted on advanced stage SOC patients (n=100) that were treated either conventionally (n=50) or with NACT (n=50), followed by surgery. In order to evaluate the expression of tissue biomarkers (p53, MIB1, estrogen and progesterone receptors, Her-2/neu, E-cadherin, and Bcl2), immunohistochemistry and semiquantitative scoring were done following morphological examination. Following NACT, significant differences in tumor histomorphology were observed as compared to the native neoplasms. MIB 1 was significantly lower in cases treated with NACT and survival outcome was significantly better in cases with low MIB 1. ER expression was associated with poor overall survival. No other marker displayed any significant difference in expression or correlation with survival between the two groups. Immunophenotype of SOC does not differ significantly in samples from cases treated with NACT, compared to upfront surgically treated cases. The proliferating capacity of the residual tumor cells is less, depicted by low mean MIB1 LI. MIB 1 and ER inversely correlate with survival.

1 August 2016 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
JSJai B. Sharma
Jai B. Sharma
SBSirisha D. Bumma
Sirisha D. Bumma
RSRenu Saxena
Renu Saxena
SKSunesh Kumar
Sunesh Kumar
KRKallol K. Roy
Kallol K. Roy
PVP. Vanamail
P. Vanamail

9 January 2009 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
JBJinee Baruah
Jinee Baruah
KRK. K. Roy
K. K. Roy
SKSunesh Kumar
Sunesh Kumar
LKLalit Kumar
Lalit Kumar

7 September 2023 in The Journal of Obstetrics and Gynecology of India
Verified
Journal Article
Closed access
PDF file
AMAnagha Menon
Anagha Menon
JMJyoti Meena
Jyoti Meena
SMSmita Manchanda
Smita Manchanda
SSSeema Singhal
Seema Singhal
SSSwati Shivhare
Swati Shivhare
SKSunesh Kumar
Sunesh Kumar